The Health Care Authority (HCA) has authorized Magellan Medicaid Administration to solicit and contract for supplemental rebates for the Apple Health Preferred Drug List (PDL).
All managed care plans and the fee-for-service program serving Apple Health clients will use this PDL. As part of the state's effort to control costs and provide clinically sound drug therapy for recipients, Provider Synergies, Magellan Medicaid Administration's sister company, will work with the Washington Drug Utilization Review (DUR) Board to expand the selection of preferred medications based on a review of the relative clinical effectiveness and cost of products within selected therapeutic classes.
The intent of the PDL is to achieve quality pharmaceutical care for recipients enrolled in the Department's Medicaid fee-for-service programs while providing significant state savings.
You may visit the Washington State Medicaid Web site at
Participation in the Supplemental Rebate Process for Washington State Medicaid
This state is now participating in the TOP$ program.
Once your company has provided contact information to Provider Synergies, your company's designated representatives will be notified when one or more of your products are under consideration for the PDL.